Correlation Between Aileron Therapeutics and Avenue Therapeutics

Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aileron Therapeutics and Avenue Therapeutics, you can compare the effects of market volatilities on Aileron Therapeutics and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Avenue Therapeutics.

Diversification Opportunities for Aileron Therapeutics and Avenue Therapeutics

0.78

Correlation Coefficient

Aileron Therapeutics  Avenue Therapeutics

Poor diversification

The 3 months correlation between Aileron and Avenue is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Avenue Therapeutics go up and down completely randomly.

Pair Corralation between Aileron Therapeutics and Avenue Therapeutics

Given the investment horizon of 90 days Aileron Therapeutics is expected to generate 1.1 times more return on investment than Avenue Therapeutics. However, Aileron Therapeutics is 1.1 times more volatile than Avenue Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Avenue Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  315.00  in Aileron Therapeutics on October 7, 2024 and sell it today you would lose (87.00) from holding Aileron Therapeutics or give up 27.62% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Aileron Therapeutics  vs.  Avenue Therapeutics

Aileron Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Aileron Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Avenue Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Avenue Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, Avenue Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Aileron Therapeutics and Avenue Therapeutics

The main advantage of trading using opposite Aileron Therapeutics and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.

The idea behind Aileron Therapeutics and Avenue Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.